載入...
Zarxio (Filgrastim-sndz): The First Biosimilar Approved by the FDA
Zarxio (filgrastim-sndz), a biosimilar for the treatment of severe chronic neutropenia
Na minha lista:
| 發表在: | P T |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MediMedia USA, Inc.
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5215272/ https://ncbi.nlm.nih.gov/pubmed/28090158 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|